Jhoann M.T. Miyajima

Jhoann M.T. Miyajima

Auto-generated profile, based on publicly available information

Jhoann M.T. Miyajima

Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01 Matrix Building, Singapore 138671, Republic of Singapore

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2023 in ACS Catalysis
Verified
Journal Article
Open access
WYWan Lin Yeo
Wan Lin Yeo
DPDillon Tay Wei Peng
Dillon Tay Wei Peng
JMJhoann M.T. Miyajima
Jhoann M.T. Miyajima
SSShreyas Supekar
Shreyas Supekar
TTTong Mei Teh
Tong Mei Teh
EAEe Lui Ang
Ee Lui Ang

31 January 2023 in Research Square
Verified
Preprint
Open access
PDF file
SMSebastian Maurer-Stroh
Sebastian Maurer-Stroh
AMAshar Malik
Ashar Malik
DKDimitar Kenanov
Dimitar Kenanov
CCCheng-Shoong Chong
Cheng-Shoong Chong
MOMert Burak Ozturk
Mert Burak Ozturk
CVChandra S Verma
Chandra S Verma
One of the promises of precision medicine is to understand and act on inter-individual genetic differences in drug responses. SNPdrug3D contains the complete genomic landscape of missense single nucleotide variants (SNV) across the human proteome and at population-wide level that could affect drug binding. In the Singapore SG10K Health and global gnomAD cohorts, comprising variations in over 80,000 individuals, we identified ~ 1.17 million variants mapped to residues near bound drug molecules in protein-drug complexes relative to ~ 6000 drug molecules and experimentally verified effects of selected SNVs, including previously uncharacterized variants, on drug binding in relevant proteins ranging from kinases to cytochrome P450s (CYPs). The latter led to a specific predictor for interpreting variants in the CYP family that vastly outperforms existing tools in the prediction of pharmacogenetic effects. By placing variants and drugs in structural context, SNPdrug3D aids drug development by early flagging of resistance potential through population-specific variability.

16 October 2026 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
VLVictor J. Y. Lim
Victor J. Y. Lim
YLYee-Song Law
Yee-Song Law
GPGuangrong Peh
Guangrong Peh
CTClarence Tan
Clarence Tan
CCCharmaine Chia
Charmaine Chia
HFHao Fan
Hao Fan